» Articles » PMID: 22037582

Crystal Structure of Human Prostate-specific Antigen in a Sandwich Antibody Complex

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2011 Nov 1
PMID 22037582
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Human prostate-specific antigen (PSA or human kallikrein-related peptidase 3) present in small quantities in the sera of healthy men becomes elevated in prostate cancer (PCa) and other prostate disorders. The ability to identify the free PSA fraction associated with PCa could increase the reliability of the PSA diagnostic test. Here we present the crystal structure of human PSA from seminal fluid in a sandwich complex with two monoclonal antibodies (mAbs). MAb 5D5A5 captures total PSA with exceptionally high affinity, and mAb 5D3D11 selectively discriminates between free PSA subforms that are more abundant in sera from patients with PCa. Although the antigen is not of seric origin, several insights into cancer diagnosis can be discerned from this complex. MAb 5D3D11 recognizes a PSA conformation different from that previously reported. Interacting with the kallikrein loop, the PSA N-linked glycan attached to asparagine 61 is an uncommonly complex sialated triantennary chain. O-linked glycosylation is observed at threonine 125. The description of how PSA subforms in prostatic fluid can be discriminated using pairs of antibodies is a first step in the design of new strategies that are capable of real discrimination among PSA subforms, which will lead to the formulation of more reliable diagnostic tests. In a companion article [Muller, B. H., Savatier, A., L'Hostis, G., Costa, N., Bossus, M., Michel, S., et al. (2011). In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay. J. Mol. Biol.], we describe engineering efforts to improve the affinity of mAb 5D3D11, a first step towards such goal.

Citing Articles

Towards Understanding the Role of the Glycosylation of Proteins Present in Extracellular Vesicles in Urinary Tract Diseases: Contributions to Cancer and Beyond.

Wilczak M, Surman M, PRZYBYlO M Molecules. 2024; 29(22).

PMID: 39598633 PMC: 11596185. DOI: 10.3390/molecules29225241.


Phage Display's Prospects for Early Diagnosis of Prostate Cancer.

Petrenko V Viruses. 2024; 16(2).

PMID: 38400052 PMC: 10892688. DOI: 10.3390/v16020277.


Prion strains viewed through the lens of cryo-EM.

Manka S, Wenborn A, Collinge J, Wadsworth J Cell Tissue Res. 2022; 392(1):167-178.

PMID: 36028585 PMC: 10113314. DOI: 10.1007/s00441-022-03676-z.


Glycosylation Changes in Prostate Cancer Progression.

Butler W, Huang J Front Oncol. 2022; 11:809170.

PMID: 35004332 PMC: 8739790. DOI: 10.3389/fonc.2021.809170.


Glycosylation: Rising Potential for Prostate Cancer Evaluation.

Kaluza A, Szczykutowicz J, Ferens-Sieczkowska M Cancers (Basel). 2021; 13(15).

PMID: 34359624 PMC: 8345048. DOI: 10.3390/cancers13153726.